Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Study of INBRX-109 in Conventional Chondrosarcoma
Sarcoma
Sarcoma
Randomized, blinded, placebo-controlled, Phase 2 study of INBRX-109 in unresectable or
metastatic conventional chondrosarcoma patients.
metastatic conventional chondrosarcoma patients.
Sarcoma
II
Davis, Elizabeth
NCT04950075
VICCSAR2165
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People with Advanced Alveolar Soft Part Sarcoma
Sarcoma
Sarcoma
This phase II trial studies how well atezolizumab or atezolizumab plus bevacizumab works in treating patients with alveolar soft part sarcoma that has not been treated, has spread from where it started to other places in the body (advanced) and cannot be removed by surgery (unresectable). Atezolizumab works by unblocking the immune system, allowing the immune system cells to recognize and then attack tumor cells. Bevacizumab works by controlling the growth of new blood vessels. Giving atezolizumab alone or atezolizumab with bevacizumab may shrink the cancer.
Sarcoma
II
Davis, Elizabeth
NCT03141684
VICCSAR16155ET-CT
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
Multiple Cancer Types
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in solid tumors
Miscellaneous,
Pediatric Solid Tumors,
Pediatrics,
Sarcoma
I/II
Davis, Elizabeth
NCT03425279
VICCSAR20117
Pilot Study of ctDNA and Imaging Characteristics as Biomarkers of Disease-related Outcomes in Patients with Localized Leiomyosarcoma Receiving Chemotherapy
Sarcoma
Sarcoma
Sarcoma
N/A
Davis, Elizabeth
NCT04925089
VICCSAR2121
Observational Study of Biomarkers of Disease-related Outcomes in Patients with Metastatic Leiomyosarcoma Receiving Chemotherapy
Sarcoma
Sarcoma
Sarcoma
N/A
Davis, Elizabeth
NCT05653388
VICC-ITSAR23169